Experience of surgical treatment of intrathoracic metastasis osteogenenic sarcoma
- Authors: Akhmedov B.B.1, Kononets P.V.1, Valiev A.K.1, Sofronov D.I.1
-
Affiliations:
- FSBI «National Medical Research Center of Oncology named after N.N. Blokhin» of the Ministry of Health of Russia
- Issue: Vol 12, No 1 (2020)
- Pages: 44-52
- Section: BONE SARCOMAS
- Published: 16.04.2020
- URL: https://sarbon.abvpress.ru/jour/article/view/80
- ID: 80
Cite item
Full Text
Abstract
Objective. The aim of the study is to improve the results of surgical treatment of metastases of osteogenic sarcomas in the lungs, analysis of factors that may affect the effectiveness of surgical treatment. Methods. The study included 120 patients with lung metastases of bone sarcomas who were treated from 1997 to 2013. Among the patients, there were 64 (53.3%) men and 56 (46.7%) women. The median age for diagnosis was 25 years (13 to 68 years). Most osteogenic tumors were osteosarcomas (56.7%). The indication for surgery in most cases (55%) was metastases in the lungs as the only manifestation of the disease. Most often, operations were performed with unilateral lung damage (57%). Results. Surgeries were predominantly performed with thoracotomy access. The most commonly performed surgeries were atypical lung resections. 23 (19%) patients required a lobectomy. In 113 (94%) patients, operations were performed in the volume of R0. Postoperative complications were noted in 10 (8.5%) patients. The most common postoperative complication was pneumonia, in 1 patient it led to postoperative mortality, in another patient - it led to pulmonary failure. The median followup in the study group was 53.2 months (from 3.5 months to 252 months). When analyzing the frequency of therapeutic pathomorphism in patients with bone sarcoma metastases who underwent chemotherapeutic treatment prior to resection, it was shown that the frequency of achieving complete therapeutic pathomorphism was relatively low - only in 5.5% of patients, in 15% moderate and in 79.5% of patients the effect of chemotherapy was not achieved or only a weak therapeutic pathomorphism was achieved. The overall 5-year survival rate in the study group was 56.4%. Conclusion. Surgical treatment can lead to long-term survival in patients with sarcoma metastases in the lungs, while the best treatment results are achieved with a long relapse-free interval, a small number of metastases and their removal in the amount of R0. Performing operations from thoracoscopic access does not worsen the long-term results of treatment.
About the authors
B. B. Akhmedov
FSBI «National Medical Research Center of Oncology named after N.N. Blokhin» of the Ministry of Health of Russia
Author for correspondence.
Email: ivlievdenis95@gmail.com
Russian Federation
P. V. Kononets
FSBI «National Medical Research Center of Oncology named after N.N. Blokhin» of the Ministry of Health of RussiaRussian Federation
A. K. Valiev
FSBI «National Medical Research Center of Oncology named after N.N. Blokhin» of the Ministry of Health of RussiaRussian Federation
D. I. Sofronov
FSBI «National Medical Research Center of Oncology named after N.N. Blokhin» of the Ministry of Health of RussiaRussian Federation
References
Supplementary files


